1. Home
  2. LASR vs DYN Comparison

LASR vs DYN Comparison

Compare LASR & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo nLIGHT Inc.

LASR

nLIGHT Inc.

HOLD

Current Price

$54.84

Market Cap

2.3B

Sector

Technology

ML Signal

HOLD

DYN

Dyne Therapeutics Inc.

HOLD

Current Price

$16.68

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LASR
DYN
Founded
2000
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.8B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
LASR
DYN
Price
$54.84
$16.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
17
Target Price
$37.86
$39.94
AVG Volume (30 Days)
1.3M
2.1M
Earning Date
02-26-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$227,526,000.00
N/A
Revenue This Year
$31.94
N/A
Revenue Next Year
$11.78
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.05
N/A
52 Week Low
$6.20
$6.36
52 Week High
$55.31
$25.00

Technical Indicators

Market Signals
Indicator
LASR
DYN
Relative Strength Index (RSI) 67.24 40.37
Support Level $41.51 $16.10
Resistance Level $55.31 $17.45
Average True Range (ATR) 3.73 1.01
MACD 0.65 -0.07
Stochastic Oscillator 98.12 15.50

Price Performance

Historical Comparison
LASR
DYN

About LASR nLIGHT Inc.

nLight Inc is a United States-based company provider of power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It designs, manufactures, and sells a range of power semiconductor lasers and fiber lasers that are typically integrated into laser systems. It operates in two segments: Laser Products, which includes semiconductor lasers, fiber lasers, and directed energy products; and Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, Asia Pacific, and EMEA.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: